Lupus Research Alliance Invites New Jersey Community to Walk with Us to Cure Lupus May 17 at MetLife Stadium
The Lupus Research Alliance (LRA) will unite thousands of dedicated lupus champions and the community at the “2025 New...
Bristol-Myers Squibb
Lupus Research Alliance Launches the DREAM Knowledge-Exchange Platform to Accelerate Precision Medicine in Lupus
The DREAM is the final component of the Lupus Research Alliance’s Lupus Nexus, an innovative program that provides unprecedented resources...
Lupus Peer-to-Peer Early Education Program Expands
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, has announced an innovative expansion of the highly...
Summary Highlights of Important Research Presented at ACR Convergence 2023
At the recent ACR Convergence 2023, the annual meeting of the American College of Rheumatology, important lupus clinical trial...
LRA Brings Encouraging News from European Rheumatology Meeting
June 2, 2022
The Lupus Research Alliance (LRA) and its clinical trial arm Lupus Therapeutics congratulate Bristol Myers Squibb (BMS)...
Lupus Clinical Trials Redefined: You Make the Difference
Lupus Clinical Trials Redefined: You Make the Difference
Lupus Clinical Trials Virtual Fair
October 17, 2020
10:00 am to 1:00 pm ET
Register...
Lupus Therapeutics Expands Collaboration with Bristol-Myers Squibb to Test Potential Treatment for Lupus
New York, NY– June 27, 2019. The Lupus Research Alliance (LRA) and clinical research affiliate, Lupus Therapeutics, broadened a collaboration...
Lupus Research Alliance and Lupus Therapeutics collaborate with Bristol-Myers Squibb on a New Lupus Trial
New York, NY. April 26, 2018. The Lupus Research Alliance today announced that the newly formed clinical affiliate Lupus...